Oncology research in Czechia
Czech Academy of Sciences ranks first in Czechia for Oncology research in 2022-now (#399 worldwide), followed by Charles University and Masaryk University.
- Czechia's world rank
- #28 of 65 countries, 2022-now
- Works, 2022-now
- 681
- Top-10% rate
- 7.8%
- Ranked institutions
- 3
This ranks research output and citation impact, not the quality of diagnosis, treatment or care.
What is the best university for Oncology in Czechia?
| # | Institution | World rank | Score | Top-10% rate | Works |
|---|---|---|---|---|---|
| 1 | Czech Academy of SciencesPrague | #399 | 9.6 | 8.2% | 81 |
| 2 | Charles UniversityPrague | #410 | 9.2 | 8.8% | 137 |
| 3 | Masaryk UniversityBrno | #444 | 8.0 | 8.4% | 70 |
Institutions in Czechia above the floor of 40 fractional works in Oncology, ordered by their worldwide rank on research quality, 2022-now.
Who are the top Oncology researchers in Czechia?
Jitka Palich Fucikova, Bohuslav Melichar and David Cibula rank highest among researchers based in Czechia, on their papers in Oncology that reached the world top 10%, beyond the 10% expected.
- 1Jitka Palich Fucikova#12,064 worldwide overall13.2 of 21 papers here in the top 10%
- 2Bohuslav Melichar#485,846 worldwide overall23.5 of 139 papers here in the top 10%
- 3David Cibula#73,673 worldwide overall15.1 of 57 papers here in the top 10%
- 4Eva Havrdová#263,852 worldwide overall13.8 of 46 papers here in the top 10%
- 5Radek Špíšek#128,042 worldwide overall13.8 of 36 papers here in the top 10%
- 6Libor Havel#165,666 worldwide overall10.7 of 32 papers here in the top 10%
- 7Marek Trněný#313,766 worldwide overall14.2 of 70 papers here in the top 10%
- 8Katarína Petráková#143,501 worldwide overall7.2 of 17 papers here in the top 10%
- 9Petr Arenberger#444,834 worldwide overall9.5 of 32 papers here in the top 10%
- 10Ivan Špıčka#355,904 worldwide overall9.8 of 44 papers here in the top 10%
- 11Lenka Foretová#68,607 worldwide overall9.0 of 39 papers here in the top 10%
Ranked among researchers based in Czechia on their work in Oncology alone: how many more of their papers here reached the world top 10% for their subfield and year than the 10% expected.